Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
114,000
Employees114,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
114,000
Employees114,000

ABT Key Statistics

Market cap
224.19B
Market cap224.19B
Price-Earnings ratio
16.17
Price-Earnings ratio16.17
Dividend yield
1.83%
Dividend yield1.83%
Average volume
8.11M
Average volume8.11M
High today
$129.38
High today$129.38
Low today
$128.01
Low today$128.01
Open price
$128.38
Open price$128.38
Volume
2.57M
Volume2.57M
52 Week high
$141.23
52 Week high$141.23
52 Week low
$110.86
52 Week low$110.86

Stock Snapshot

With a market cap of 224.19B, Abbott(ABT) trades at $129.00. The stock has a price-to-earnings ratio of 16.17 and currently yields dividends of 1.8%.

On 2025-11-30, Abbott(ABT) stock moved within a range of $128.01 to $129.38. With shares now at $129.00, the stock is trading +0.8% above its intraday low and -0.3% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 2.57M, versus its average volume of 8.11M.

The stock's 52-week range extends from a low of $110.86 to a high of $141.23.

The stock's 52-week range extends from a low of $110.86 to a high of $141.23.

ABT News

Nasdaq 10h
This Top Dividend King Just Became an Even Better Buy

Key Points Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact...

This Top Dividend King Just Became an Even Better Buy
Nasdaq 2d
Peter Lynch Detailed Fundamental Analysis - ABT

Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor m...

Peter Lynch Detailed Fundamental Analysis - ABT
Simply Wall St 3d
How Abbott’s Medical Device Advances Are Shaping Its 2025 Valuation Debate

Wondering if Abbott Laboratories is delivering real value for its current price? You are not alone. The stock often sits high on watchlists for investors assess...

How Abbott’s Medical Device Advances Are Shaping Its 2025 Valuation Debate

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
32.3%
Sell
0%

More ABT News

Simply Wall St 4d
Assessing Abbott Laboratories Valuation Following Steady 2024 Gains and Analyst Growth Projections

Abbott Laboratories (ABT) shares have shown modest movement lately, with a daily uptick of nearly 1% and a year-to-date climb of 13%. Investors appear to be tak...

Assessing Abbott Laboratories Valuation Following Steady 2024 Gains and Analyst Growth Projections
Barchart 4d
Is Abbott Laboratories Stock Underperforming the S&P 500?

North Chicago, Illinois-based Abbott Laboratories ( ABT ) discovers, develops & manufactures a diversified line of healthcare products. Valued at $221.2 billion...

TipRanks 5d
Top Abbott Exec Cashes In on Stock Sale!

New insider activity at Abbott Laboratories ( (ABT) ) has taken place on November 25, 2025. TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the da...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.